Yüklüyor......
Targeted therapy in SDH-deficient GIST
The medical management of advanced gastrointestinal stromal tumors (GIST) has improved with the development of tyrosine kinase inhibitors (TKIs) targeting KIT and PDGFRA mutations. However, approximately 5–10% of GIST lack KIT and PDGFRA mutations, and about a half are deficient in succinate dehydro...
Kaydedildi:
| Yayımlandı: | Ther Adv Med Oncol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8246492/ https://ncbi.nlm.nih.gov/pubmed/34262616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17588359211023278 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|